Alnylam must wait a few months longer for a verdict on its potential blockbuster-in-waiting vutrisiran.
With tax day right around the corner in the U.S., Merck & Co. is the latest Big Pharma to find itself in the crosshairs of a congressional tax probe.
Animal studies show live biotherapeutic produced by gut-healthy probiotic bacteria is safe, reduces treatment complications.
A new tool speeds up development of vaccines and other pharmaceutical products by more than 1 million times while minimizing costs.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.
